
Sign up to save your podcasts
Or


McDonald’s reports historically bad sales numbers. Merck buys Cubist Pharmaceuticals for $9.5 billion. And we dip into the Fool Mailbag to explore the future of fracking.
By The Motley Fool4.7
16041,604 ratings
McDonald’s reports historically bad sales numbers. Merck buys Cubist Pharmaceuticals for $9.5 billion. And we dip into the Fool Mailbag to explore the future of fracking.

3,221 Listeners

1,487 Listeners

808 Listeners

948 Listeners

520 Listeners

1,168 Listeners

2,184 Listeners

825 Listeners

1,423 Listeners

1,039 Listeners

9,717 Listeners

195 Listeners

826 Listeners

85 Listeners

585 Listeners

1,039 Listeners

54 Listeners